PARKINSON'S DISEASE DEMENTIA: AT THE CROSSROADS OF α-SYNUCLEIN, TAU AND AMYLOID-β

被引：0
|
作者：
Irwin, David [1 ]
Lee, V. [1 ]
Trojanowski, J. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
NEUROBIOLOGY OF AGING | 2014年 / 35卷
关键词：
Parkinson's disease; Dementia; Neuropathology;
D O I：
10.1016/j.neurobiolaging.2014.01.070
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [21] Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease
    Glenda M. Halliday
    Yun Ju C. Song
    Antony J. Harding
    Journal of Neural Transmission, 2011, 118
  • [22] Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease
    Pan, Lina
    Li, Chunrui
    Meng, Lanxia
    Tian, Ye
    He, Mingyang
    Yuan, Xin
    Zhang, Guoxin
    Zhang, Zhaohui
    Xiong, Jing
    Chen, Guiqin
    Zhang, Zhentao
    BRAIN, 2022, 145 (10) : 3454 - 3471
  • [23] Amyloid beta-peptide and the dementia of Parkinson's disease
    Jendroska, K
    Lees, AJ
    Poewe, W
    Daniel, SE
    MOVEMENT DISORDERS, 1996, 11 (06) : 647 - 653
  • [24] The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies
    Ferman, Tanis J.
    Aoki, Naoya
    Crook, Julia E.
    Murray, Melissa E.
    Graff-Radford, Neill R.
    van Gerpen, Jay A.
    Uitti, Ryan J.
    Wszolek, Zbigniew K.
    Graff-Radford, Jonathan
    Pedraza, Otto
    Kantarci, Kejal
    Boeve, Bradley F.
    Dickson, Dennis W.
    ALZHEIMERS & DEMENTIA, 2018, 14 (03) : 330 - 339
  • [25] Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson’s disease
    Fardin Nabizadeh
    Fatemeh Sodeifian
    Amirhosein Kargar
    Acta Neurologica Belgica, 2023, 123 : 1429 - 1437
  • [26] Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein
    Araki, Katsuya
    Yagi, Naoto
    Aoyama, Koki
    Choong, Chi-Jing
    Hayakawa, Hideki
    Fujimura, Harutoshi
    Nagai, Yoshitaka
    Goto, Yuji
    Mochizuki, Hideki
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (36) : 17963 - 17969
  • [27] Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
    Valera, Elvira
    Spencer, Brian
    Masliah, Eliezer
    NEUROTHERAPEUTICS, 2016, 13 (01) : 179 - 189
  • [28] CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
    Alves, Guido
    Bronnick, Kolbjorn
    Aarsland, Dag
    Blennow, Kaj
    Zetterberg, Henrik
    Ballard, Clive
    Kurz, Martin Wilhelm
    Andreasson, Ulf
    Tysnes, Ole-Bjorn
    Larsen, Jan Petter
    Mulugeta, Ezra
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (10) : 1080 - 1086
  • [29] Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old
    Robinson, John L.
    Geser, Felix
    Corrada, Maria M.
    Berlau, Daniel J.
    Arnold, Steven E.
    Lee, Virginia M. -Y.
    Kawas, Claudia H.
    Trojanowski, John Q.
    BRAIN, 2011, 134 : 3705 - 3712
  • [30] New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease
    Zhang, Feng
    Zhong, Ru-jia
    Cheng, Cheng
    Li, Song
    Le, Wei-dong
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (09) : 1382 - 1389
12345